Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Capital Expenditures (2019 - 2025)

Volitionrx's Capital Expenditures history spans 9 years, with the latest figure at $10967.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 84.89% year-over-year to $10967.0; the TTM value through Dec 2025 reached $89558.0, down 67.73%, while the annual FY2025 figure was $89558.0, 67.73% down from the prior year.
  • Capital Expenditures reached $10967.0 in Q4 2025 per VNRX's latest filing, down from $76783.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $775027.0 in Q3 2023 to a low of -$775027.0 in Q4 2023.
  • Average Capital Expenditures over 5 years is $153199.9, with a median of $128572.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: surged 350.14% in 2022, then plummeted 233.91% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $128572.0 in 2021, then soared by 350.14% to $578752.0 in 2022, then tumbled by 233.91% to -$775027.0 in 2023, then surged by 109.37% to $72601.0 in 2024, then tumbled by 84.89% to $10967.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Capital Expenditures are $10967.0 (Q4 2025), $76783.0 (Q2 2025), and $1808.0 (Q1 2025).